Yeong-Min Park Selected Research

Yeong-Min Park Research Topics

Disease

59	Neoplasms (Cancer) 12/2022 - 12/2003
14	Inflammation (Inflammations) 12/2020 - 10/2003
12	Asthma (Bronchial Asthma) 03/2015 - 03/2006
8	Respiratory Hypersensitivity 03/2015 - 01/2007
7	Sepsis (Septicemia) 08/2019 - 03/2009
7	Septic Shock (Toxic Shock Syndrome) 05/2017 - 10/2003
6	Infections 12/2020 - 03/2014
6	Neoplasm Metastasis (Metastasis) 01/2019 - 12/2003
4	Ovarian Epithelial Carcinoma 01/2020 - 01/2016
4	Endotoxemia 08/2019 - 07/2011
4	Breast Neoplasms (Breast Cancer) 06/2018 - 09/2011
3	Melanoma (Melanoma, Malignant) 12/2021 - 05/2017
3	Carcinoma (Carcinomatosis) 01/2020 - 05/2006
3	Thymoma (Thymic Carcinoma) 05/2015 - 02/2013
3	Paratuberculosis (Johne's Disease) 02/2014 - 07/2009
3	Chronic Disease (Chronic Diseases) 12/2008 - 06/2005
2	Alzheimer Disease (Alzheimer's Disease) 12/2021 - 06/2006
2	Liver Neoplasms (Liver Cancer) 01/2021 - 01/2006
2	Immune System Diseases (Immune Disorders) 07/2018 - 10/2013
2	Shock 01/2017 - 08/2009
2	Experimental Arthritis 03/2016 - 06/2003
2	Prostatic Neoplasms (Prostate Cancer) 05/2013 - 09/2011
1	Bites and Stings (Sting) 12/2022

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 12/2021 - 06/2007
14	CytokinesIBA 12/2022 - 10/2003
14	VaccinesIBA 12/2022 - 01/2007
13	AntigensIBA 12/2021 - 01/2007
12	OvalbuminIBA 01/2016 - 01/2007
9	LipopolysaccharidesIBA 12/2021 - 10/2003
7	Pharmaceutical PreparationsIBA 08/2019 - 05/2006
6	Peptides (Polypeptides)IBA 12/2022 - 09/2015
6	Interleukin-10 (Interleukin 10)IBA 01/2018 - 03/2009
6	CurcuminIBA 01/2013 - 06/2005
5	Small Interfering RNA (siRNA)IBA 01/2022 - 02/2006
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2021 - 10/2003
5	Toll-Like Receptor 4IBA 04/2021 - 07/2011
5	Neoplasm Antigens (Tumor Antigens)IBA 04/2021 - 12/2005
5	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 05/2015 - 03/2007
4	Immune Checkpoint InhibitorsIBA 12/2022 - 01/2020
4	InterferonsIBA 12/2022 - 05/2015
4	Liposomes (Liposome)IBA 12/2021 - 10/2013
4	LigandsIBA 12/2020 - 05/2007
4	Interleukin-12 (IL 12)IBA 04/2016 - 10/2003
4	Glycogen Synthase (Synthase I)IBA 01/2016 - 07/2011
4	Phenobarbital (Luminal)FDA Link 03/2015 - 01/2007
4	Methacholine Chloride (Methacholine)FDA Link 05/2012 - 09/2008
4	Proteoglycans (Proteoglycan)IBA 09/2005 - 06/2003
3	B7-H1 AntigenIBA 12/2022 - 12/2021
3	Cancer VaccinesIBA 04/2021 - 05/2012
3	Polylactic Acid-Polyglycolic Acid CopolymerIBA 02/2020 - 01/2016
3	Phosphotransferases (Kinase)IBA 08/2019 - 07/2011
3	Paclitaxel (Taxol)FDA LinkGeneric 11/2018 - 01/2016
3	ResveratrolIBA 05/2015 - 06/2006
3	Immunologic Adjuvants (Immunologic Adjuvant)IBA 08/2014 - 05/2012
3	AllergensIBA 05/2012 - 04/2011
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2008 - 05/2006
3	Polysaccharides (Glycans)IBA 11/2004 - 10/2003
2	Interferon-gamma (Interferon, gamma)IBA 12/2022 - 02/2006
2	Cisplatin (Platino)FDA LinkGeneric 12/2022 - 12/2021
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 01/2020
2	Pattern Recognition ReceptorsIBA 12/2020 - 03/2014
2	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2020 - 01/2016
2	Annexin A5IBA 01/2020 - 09/2016
2	linaloolIBA 01/2020 - 01/2016
2	PolyphenolsIBA 01/2020 - 05/2006
2	Therapeutic UsesIBA 08/2019 - 03/2011
2	Hyaluronic Acid (Hyaluronan)IBA 11/2018 - 11/2018
2	Focal Adhesion Protein-Tyrosine KinasesIBA 11/2018 - 04/2017
2	ChitosanIBA 11/2018 - 12/2016
2	Messenger RNA (mRNA)IBA 11/2018 - 06/2007
2	nobiletinIBA 06/2018 - 04/2017
2	Vaccine AdjuvantsIBA 01/2018 - 09/2015
2	QuercetinIBA 01/2018 - 03/2009
2	EndotoxinsIBA 01/2018 - 05/2017
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2017 - 01/2012
2	Platelet Activating FactorIBA 01/2017 - 08/2009
2	Interleukin-6 (Interleukin 6)IBA 04/2016 - 12/2006
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2016 - 03/2014
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2015 - 08/2014
2	Biological ProductsIBA 05/2013 - 07/2006
2	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2013 - 09/2011
2	Fibronectins (Fibronectin)IBA 05/2012 - 07/2009
2	sulforaphaneIBA 05/2012 - 05/2007
2	InterleukinsIBA 04/2012 - 02/2012
2	Glycogen Synthase Kinase 3IBA 04/2012 - 07/2011
2	EnzymesIBA 02/2009 - 03/2007
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2008 - 12/2006
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2008 - 06/2006
2	pinitolIBA 06/2007 - 01/2007
2	CaspasesIBA 01/2006 - 06/2005
1	vadimezanIBA 12/2022
1	Interferon Type IIBA 12/2022
1	HydrogelsIBA 12/2021
1	GoldIBA 12/2021

Therapy/Procedure

18	Immunotherapy 12/2022 - 12/2005
14	Therapeutics 12/2022 - 03/2006
9	Drug Therapy (Chemotherapy) 12/2022 - 01/2007
1	Radiotherapy 12/2022
1	Injections 12/2021
1	Operative Surgical Procedures 12/2021